Leads from the MMWR. Human T-lymphotropic virus type III/lymphadenopathy-associated virus: agent summary statement.
出版信息
JAMA. 1986 Oct 10;256(14):1857, 1861, 1868 passim.
PMID:3020262
Abstract
摘要
相似文献
1
Leads from the MMWR. Human T-lymphotropic virus type III/lymphadenopathy-associated virus: agent summary statement.《发病率与死亡率周报》报道。人类嗜T淋巴细胞病毒III型/淋巴结病相关病毒：病原体总结声明。
JAMA. 1986 Oct 10;256(14):1857, 1861, 1868 passim.
2
Human T-lymphotropic virus type III/lymphadenopathy-associated virus: agent summary statement.人类嗜T淋巴细胞病毒III型/淋巴结病相关病毒：病原体总结声明。
MMWR Morb Mortal Wkly Rep. 1986 Aug 29;35(34):540-2, 547-9.
3
4
[Guidelines for the management of patients infected by the human immunodeficiency virus].[人类免疫缺陷病毒感染患者的管理指南]
Rev Invest Clin. 1988 Jan-Mar;40(1):47-63.
6
7
HIV/lymphadenopathy-associated virus: agent summary statement. Centers for Disease Control.人类免疫缺陷病毒/淋巴结病相关病毒：病原体总结声明。疾病控制中心。
Ohio Med. 1988 Feb;84(2):127-31.
8
Leads from the MMWR. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome.
JAMA. 1987 Sep 4;258(9):1143-5, 1149, 1153-4.
9
HIV testing for NIH laboratory workers gets under way.
Nature. 1988 Mar 31;332(6163):386. doi: 10.1038/332386c0.
10
Infection control measures for human immunodeficiency virus (HIV): universal precautions.人类免疫缺陷病毒（HIV）的感染控制措施：通用防护措施
J Okla State Med Assoc. 1988 Sep;81(9):575-6.
Zotero 插件